<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN">
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=UTF-8">
    <title>Description of interventions_9</title>
    <link href="data:image/x-icon;base64,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" rel="icon" type="image/x-icon">
    <style>@import "https://fonts.googleapis.com/css?family=Source+Sans+Pro:ital,wgth:0,400;0,700;1,400;1,700";body {  font-family: "Source Sans Pro", sans-serif;  margin: 40px;}@media screen {  #backToTop {    position: fixed;    bottom: 0px;    left: 50%;    transform: translateX(-50%);    border-radius: 4px 4px 0 0;    padding: 4px 12px 4px 12px;    background: #1f3c73;    font-weight: bold;  }  #backToTop a {    color: white;  }}@media print {  #backToTop {    display: none;  }}table {  width: fit-content;  border-collapse: collapse;}th {  font-weight: bold;  background: LightGray;}td, th {  border: 1px solid LightGray;  padding: 8px;  font-size: 14px;  vertical-align: top;}caption {  font-weight: bold;  font-size: large;  text-align: left;  padding: 8px;}h1 {  font-size:38.5px;}h2 {  font-size:31.5px;}h1 small, h3 {  font-size:24.5px;}h2 small, h4 {  font-size:17.5px;}h3 small, h4 small, h5 {  font-size:14px;}h6 {  font-size:11.9px;}a {  color: #002d64;  text-decoration: none;}.byline {  font-weight: bold;  color: #002D64;}.disclaimer {  font-style: italic;}figure, table.analysis {  width: fit-content;  display: block;  margin-block-start: 1em;  margin-block-end: 1em;  margin-inline-start: 40px;  margin-inline-end: 40px;}thead tr td, th, figcaption, caption {  font-weight: bold;  background: LightGray;}span.inserted {  background-color: #e5ffcd;}span.deleted {  background-color: #e5ffcd;  text-decoration: line-through;}span.marker-yellow {  background-color: #ffff80;}ol ol {  list-style-type: lower-alpha;}ol ol ol {  list-style-type: lower-roman;}</style>
  </head>
  <body>
    <div class="logo">
      <svg xmlns="http://www.w3.org/2000/svg" height="57" viewBox="0 0 1138.5 192" width="338" xml:space="preserve">
        <path d="M86 .5v33a63.3 63.3 0 0 0 0 125v33a96 96 0 0 1 0-191zM106 .5v33a63.3 63.3 0 0 1 0 125v33a96 96 0 0 0 0-191z" fill="#1f3c73"></path>
        <path d="M93 0h6v192h-6z" fill="#a53995"></path>
        <path d="M93 0h6v192h-6zM82 44h8v6h-8z" fill="#a53995"></path>
        <path d="M63 58h40v6H63zM69 73h30v6H69zM78 86h36v6H78zM63 100h42v6H63zM60 114h28v6H60zM88 128h15v6H88zM84 140l6 6-6 6-6-6z" fill="#a53995"></path>
        <g aria-label="Cochrane" fill="#1f3c73" stroke-width="3.368">
          <path d="M256.96 82.722q-7.366 0-13.564-3.413-6.198-3.414-9.97-10.06-3.683-6.737-3.683-16.528 0-9.701 3.772-16.528 3.863-6.917 10.15-10.51 6.378-3.682 13.743-3.682 5.66 0 10.15 2.335 4.492 2.246 7.456 5.3l-7.007 8.443q-2.245-2.066-4.76-3.323-2.426-1.347-5.57-1.347-3.952 0-7.275 2.245-3.234 2.246-5.21 6.468-1.886 4.221-1.886 10.15 0 8.982 3.862 14.013 3.863 5.03 10.33 5.03 3.593 0 6.378-1.617 2.874-1.617 5.03-3.863l7.006 8.264q-7.365 8.624-18.953 8.624zM302.86 82.722q-5.659 0-10.689-2.695-4.94-2.784-7.994-7.994-3.054-5.3-3.054-12.665 0-7.456 3.054-12.665 3.054-5.21 7.994-7.905 5.03-2.784 10.689-2.784t10.599 2.784q4.94 2.695 7.994 7.905 3.054 5.21 3.054 12.665 0 7.365-3.054 12.665-3.054 5.21-7.994 7.994-4.94 2.695-10.599 2.695zm0-10.689q4.042 0 6.108-3.413 2.066-3.504 2.066-9.252 0-5.839-2.066-9.252-2.066-3.413-6.108-3.413-4.132 0-6.198 3.413-1.976 3.413-1.976 9.252 0 5.749 1.976 9.252 2.066 3.413 6.198 3.413zM352.98 82.722q-6.198 0-11.228-2.695-4.94-2.784-7.905-7.994-2.874-5.3-2.874-12.665 0-7.456 3.234-12.665 3.233-5.21 8.533-7.905 5.3-2.784 11.408-2.784 4.132 0 7.276 1.347 3.234 1.348 5.749 3.413l-6.198 8.534q-3.144-2.605-6.018-2.605-4.761 0-7.636 3.413-2.784 3.413-2.784 9.252 0 5.749 2.784 9.252 2.875 3.413 7.186 3.413 2.156 0 4.222-.898 2.066-.988 3.773-2.335l5.21 8.623q-3.324 2.874-7.186 4.132-3.863 1.167-7.546 1.167zM375.53 81.644V18.677h13.204v15.45l-.629 7.994q2.515-2.245 5.839-4.131 3.413-1.977 7.904-1.977 7.276 0 10.51 4.85 3.323 4.762 3.323 13.115v27.666h-13.204v-25.96q0-4.85-1.347-6.646-1.258-1.797-4.132-1.797-2.515 0-4.312 1.168-1.796 1.078-3.952 3.144v30.091zM426.82 81.644V37.091h10.779l.898 7.815h.36q2.425-4.491 5.838-6.647 3.413-2.246 6.827-2.246 1.886 0 3.144.27 1.257.18 2.156.628l-2.156 11.408q-1.168-.359-2.336-.539-1.078-.18-2.515-.18-2.515 0-5.3 1.887-2.694 1.797-4.49 6.288v25.869zM471.28 82.722q-6.108 0-9.701-3.862-3.593-3.953-3.593-9.612 0-7.006 5.928-10.959 5.929-3.952 19.133-5.3-.18-2.964-1.796-4.67-1.527-1.797-5.21-1.797-2.785 0-5.659 1.078-2.874 1.078-6.108 2.964l-4.76-8.713q4.221-2.605 8.982-4.222 4.85-1.616 10.06-1.616 8.533 0 13.114 4.94 4.58 4.94 4.58 15.18v25.51h-10.778l-.898-4.581h-.36q-2.784 2.515-6.018 4.132-3.144 1.527-6.916 1.527zm4.491-10.24q2.246 0 3.863-.988 1.706-1.078 3.413-2.785v-7.814q-7.006.898-9.701 2.874-2.695 1.886-2.695 4.491 0 2.156 1.348 3.234 1.437.988 3.772.988zM507.39 81.644V37.091h10.779l.898 5.659h.36q2.874-2.695 6.287-4.671 3.503-2.066 7.995-2.066 7.275 0 10.509 4.85 3.323 4.761 3.323 13.115v27.666h-13.204v-25.96q0-4.85-1.347-6.646-1.258-1.797-4.132-1.797-2.515 0-4.312 1.168-1.796 1.078-3.952 3.144v30.09zM578.71 82.722q-6.378 0-11.498-2.785-5.12-2.784-8.084-7.994-2.964-5.21-2.964-12.575 0-7.276 2.964-12.486 3.054-5.21 7.904-7.994 4.85-2.875 10.15-2.875 6.378 0 10.51 2.875 4.221 2.784 6.287 7.635 2.156 4.76 2.156 10.869 0 1.706-.18 3.413-.18 1.617-.36 2.425h-26.677q.898 4.85 4.042 7.186 3.144 2.246 7.545 2.246 4.761 0 9.612-2.964l4.4 7.994q-3.412 2.335-7.634 3.683-4.222 1.347-8.174 1.347zm-9.88-28.205h16.078q0-3.683-1.796-6.018-1.707-2.426-5.66-2.426-3.053 0-5.479 2.156-2.425 2.066-3.143 6.288z"></path>
        </g>
        <g aria-label="Library" fill="#a53995" stroke-width="3.368">
          <path d="M236.48 168.68v-58.925h7.455v52.547h25.78v6.378zM279.42 168.68v-43.655h7.366v43.655zm3.773-52.637q-2.156 0-3.593-1.258-1.348-1.347-1.348-3.593 0-2.155 1.348-3.503 1.437-1.347 3.593-1.347 2.155 0 3.503 1.347 1.437 1.348 1.437 3.503 0 2.246-1.437 3.593-1.348 1.258-3.503 1.258zM320.82 169.76q-3.054 0-6.378-1.437-3.233-1.527-6.108-4.132h-.27l-.628 4.491h-5.928v-63.955h7.365v17.426l-.18 7.905q2.965-2.605 6.468-4.312 3.593-1.796 7.186-1.796 8.533 0 12.935 6.018 4.401 6.018 4.401 16.168 0 7.455-2.694 12.755-2.605 5.3-6.917 8.084-4.222 2.785-9.252 2.785zm-1.258-6.198q5.39 0 8.893-4.58 3.593-4.672 3.593-12.756 0-7.186-2.695-11.587-2.605-4.491-8.803-4.491-2.784 0-5.659 1.527-2.874 1.527-6.018 4.401v22.905q2.875 2.515 5.66 3.593 2.874.988 5.03.988zM351.19 168.68v-43.655h6.108l.629 7.905h.27q2.245-4.132 5.479-6.558 3.233-2.425 6.916-2.425 2.605 0 4.671.898l-1.437 6.468q-1.078-.36-1.976-.54-.899-.179-2.246-.179-2.784 0-5.838 2.246-2.965 2.245-5.21 7.814v28.025zM390.26 169.76q-5.48 0-9.162-3.234-3.593-3.323-3.593-9.162 0-7.186 6.377-10.959 6.468-3.862 20.39-5.39 0-2.784-.808-5.299-.719-2.515-2.695-4.042-1.886-1.617-5.479-1.617-3.773 0-7.096 1.437-3.324 1.438-5.928 3.234l-2.875-5.12q3.054-1.976 7.456-3.773 4.49-1.886 9.7-1.886 7.995 0 11.588 4.94 3.593 4.851 3.593 13.026v26.768h-6.108l-.63-5.21h-.269q-3.054 2.515-6.736 4.401-3.593 1.886-7.725 1.886zm2.156-5.928q3.144 0 5.928-1.527 2.785-1.527 5.929-4.312v-12.126q-10.87 1.347-15.27 4.042-4.312 2.695-4.312 6.917 0 3.682 2.246 5.39 2.245 1.616 5.479 1.616zM425.47 168.68v-43.655h6.108l.629 7.905h.27q2.245-4.132 5.479-6.558 3.233-2.425 6.916-2.425 2.605 0 4.671.898l-1.437 6.468q-1.078-.36-1.976-.54-.898-.179-2.246-.179-2.784 0-5.838 2.246-2.965 2.245-5.21 7.814v28.025zM459.6 187.45q-1.437 0-2.785-.27-1.257-.269-2.335-.628l1.437-5.839q.719.18 1.617.36.898.269 1.707.269 3.683 0 6.108-2.695 2.425-2.605 3.772-6.647l.988-3.233-17.516-43.745h7.636l8.892 24.163q.988 2.784 2.066 6.018 1.168 3.233 2.156 6.287h.36q.987-2.964 1.886-6.197.898-3.234 1.796-6.109l7.815-24.163h7.186l-16.438 47.248q-1.527 4.312-3.683 7.725-2.066 3.414-5.21 5.39-3.054 2.066-7.455 2.066z"></path>
        </g>
        <g aria-label="Trusted evidence." fill="#1f3c73" stroke-width="3.368">
          <path d="M710.25 61.723V30.141h-10.671v-3.773h25.869v3.773h-10.671v31.582zM728.9 61.723V35.53h3.665l.377 4.743h.162q1.347-2.48 3.287-3.935t4.15-1.455q1.563 0 2.803.54l-.863 3.88q-.646-.216-1.185-.324-.54-.108-1.348-.108-1.67 0-3.503 1.348-1.778 1.347-3.126 4.689v16.815zM755.25 62.37q-4.15 0-6.09-2.587-1.94-2.64-1.94-7.653v-16.6h4.473v16.007q0 3.665 1.132 5.336 1.185 1.67 3.772 1.67 2.048 0 3.611-1.024 1.617-1.078 3.45-3.395V35.53h4.42v26.193h-3.666l-.377-4.096h-.162q-1.832 2.156-3.88 3.45-2.048 1.293-4.743 1.293zM783.76 62.37q-2.803 0-5.336-1.024-2.533-1.078-4.419-2.587l2.21-2.964q1.724 1.347 3.557 2.263 1.832.863 4.15.863 2.587 0 3.88-1.186 1.294-1.24 1.294-2.91 0-1.348-.917-2.264-.862-.916-2.263-1.509-1.348-.647-2.803-1.186-1.832-.7-3.61-1.562-1.78-.917-2.911-2.318-1.132-1.455-1.132-3.665 0-3.18 2.372-5.281 2.425-2.156 6.683-2.156 2.425 0 4.527.862t3.61 2.102l-2.155 2.802q-1.347-1.024-2.803-1.67-1.455-.647-3.18-.647-2.479 0-3.664 1.132-1.132 1.132-1.132 2.64 0 1.24.809 2.049.808.754 2.101 1.347 1.294.539 2.749 1.132 1.886.7 3.719 1.617 1.832.862 3.018 2.371 1.24 1.455 1.24 3.934 0 2.102-1.132 3.88-1.078 1.78-3.234 2.857-2.102 1.078-5.228 1.078zM806.67 62.37q-4.204 0-5.875-2.425-1.616-2.426-1.616-6.306V39.141h-3.88V35.8l4.095-.27.54-7.33h3.718v7.33h7.06v3.61h-7.06v14.553q0 2.425.862 3.773.916 1.293 3.18 1.293.7 0 1.509-.216l1.455-.485.863 3.342q-1.078.377-2.372.647-1.24.323-2.479.323zM826.5 62.37q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.071-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.562 2.91q-1.67 1.078-3.826 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM851.56 62.37q-4.904 0-7.869-3.557-2.964-3.61-2.964-10.132 0-4.258 1.563-7.33 1.617-3.126 4.204-4.796 2.64-1.671 5.605-1.671 2.264 0 3.934.808 1.671.809 3.396 2.21l-.216-4.473V23.35h4.473v38.373h-3.664l-.378-3.072h-.161q-1.51 1.509-3.557 2.64-2.048 1.079-4.366 1.079zm.97-3.719q3.45 0 6.683-3.61V41.35q-1.67-1.509-3.234-2.102-1.509-.646-3.126-.646-2.101 0-3.826 1.293-1.67 1.24-2.695 3.503-1.024 2.21-1.024 5.228 0 4.69 1.886 7.384 1.887 2.64 5.336 2.64zM893.92 62.37q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743t-1.67-7.33q0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.659-1.67 5.012 0 7.706 3.341 2.75 3.342 2.75 8.947 0 .7-.055 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.617-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.796.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.959 2.156-2.155 2.102-2.587 5.982zM915.97 61.723l-9.432-26.193h4.581l4.959 14.875 1.185 3.88q.647 1.94 1.24 3.827h.216q.592-1.886 1.185-3.827.647-1.94 1.186-3.88l4.958-14.875h4.366l-9.27 26.193zM935.48 61.723V35.53h4.42v26.193zm2.264-31.582q-1.294 0-2.156-.755-.809-.808-.809-2.155 0-1.294.809-2.102.862-.809 2.156-.809 1.293 0 2.101.809.863.808.863 2.102 0 1.347-.862 2.155-.809.755-2.102.755zM957.68 62.37q-4.904 0-7.869-3.557-2.964-3.61-2.964-10.132 0-4.258 1.563-7.33 1.617-3.126 4.204-4.796 2.64-1.671 5.605-1.671 2.264 0 3.934.808 1.671.809 3.396 2.21l-.216-4.473V23.35h4.473v38.373h-3.664l-.378-3.072h-.161q-1.51 1.509-3.557 2.64-2.048 1.079-4.366 1.079zm.97-3.719q3.45 0 6.683-3.61V41.35q-1.67-1.509-3.234-2.102-1.509-.646-3.126-.646-2.101 0-3.826 1.293-1.67 1.24-2.695 3.503-1.024 2.21-1.024 5.228 0 4.69 1.887 7.384 1.886 2.64 5.335 2.64zM989.26 62.37q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743t-1.67-7.33q0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM1005.4 61.723V35.53h3.665l.377 3.773h.162q1.886-1.887 3.988-3.126 2.102-1.294 4.797-1.294 4.15 0 6.036 2.641 1.94 2.587 1.94 7.6v16.6h-4.42V45.715q0-3.665-1.185-5.335t-3.773-1.671q-1.994 0-3.61 1.024-1.563 1.024-3.558 3.018v18.971zM1045.2 62.37q-3.45 0-6.252-1.617t-4.42-4.689q-1.616-3.072-1.616-7.383 0-4.42 1.725-7.492 1.778-3.072 4.635-4.688 2.91-1.617 6.251-1.617 2.587 0 4.42.916 1.886.916 3.233 2.156l-2.263 2.91q-1.132-1.024-2.425-1.67-1.24-.647-2.803-.647-2.371 0-4.258 1.293-1.832 1.24-2.91 3.557-1.024 2.264-1.024 5.282 0 4.473 2.21 7.276 2.263 2.748 5.874 2.748 1.833 0 3.396-.754 1.563-.809 2.748-1.887l1.94 2.965q-1.778 1.563-3.934 2.479-2.156.862-4.527.862zM1068.9 62.37q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.071-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.659-1.67 5.012 0 7.707 3.341 2.748 3.342 2.748 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.678q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.617-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.724-6.036-1.671-2.102-4.743-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM1087.4 62.37q-1.347 0-2.317-.916-.917-.97-.917-2.426 0-1.562.917-2.479.97-.97 2.317-.97 1.294 0 2.21.97.97.916.97 2.48 0 1.455-.97 2.425-.916.916-2.21.916z"></path>
        </g>
        <g aria-label="Informed decisions." fill="#1f3c73" stroke-width="3.368">
          <path d="M699.58 124.7V89.345h4.473V124.7zM713.32 124.7V98.507h3.665l.377 3.773h.162q1.886-1.887 3.988-3.126 2.102-1.294 4.797-1.294 4.15 0 6.036 2.641 1.94 2.587 1.94 7.6v16.6h-4.42v-16.008q0-3.665-1.185-5.335-1.186-1.671-3.773-1.671-1.994 0-3.61 1.024-1.564 1.024-3.558 3.018V124.7zM743.56 124.7v-22.582h-3.557v-3.341l3.557-.27v-4.15q0-3.988 1.832-6.306 1.887-2.371 5.821-2.371 1.24 0 2.371.27 1.132.215 1.995.592l-.97 3.396q-1.456-.647-2.965-.647-3.665 0-3.665 5.066v4.15h5.552v3.61h-5.552V124.7zM768.19 125.35q-3.18 0-5.982-1.617-2.749-1.617-4.474-4.689-1.67-3.072-1.67-7.383 0-4.42 1.67-7.492 1.725-3.072 4.474-4.688 2.802-1.617 5.982-1.617 3.234 0 5.982 1.617 2.749 1.616 4.42 4.688 1.724 3.072 1.724 7.492 0 4.311-1.724 7.383-1.671 3.072-4.42 4.69t-5.982 1.616zm0-3.665q3.395 0 5.443-2.748 2.102-2.803 2.102-7.276 0-4.527-2.102-7.33-2.048-2.802-5.443-2.802-3.341 0-5.443 2.802t-2.102 7.33q0 4.473 2.102 7.276 2.102 2.748 5.443 2.748zM787.21 124.7V98.507h3.665l.377 4.743h.162q1.347-2.48 3.287-3.935t4.15-1.455q1.563 0 2.803.54l-.863 3.88q-.646-.216-1.185-.324-.54-.108-1.348-.108-1.67 0-3.503 1.348-1.778 1.347-3.126 4.689V124.7zM805.91 124.7V98.507h3.665l.377 3.773h.162q1.724-1.887 3.772-3.126 2.048-1.294 4.366-1.294 3.018 0 4.689 1.348 1.724 1.293 2.533 3.664 2.048-2.21 4.15-3.61 2.101-1.402 4.473-1.402 4.042 0 5.982 2.641 1.994 2.587 1.994 7.6v16.6h-4.42v-16.008q0-3.665-1.185-5.335-1.186-1.671-3.665-1.671-2.91 0-6.575 4.042V124.7h-4.42v-16.007q0-3.665-1.185-5.336-1.186-1.67-3.719-1.67-2.91 0-6.575 4.042v18.97zM861.21 125.35q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.071-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.562 2.91q-1.67 1.078-3.826 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.724-6.036-1.671-2.102-4.743-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM886.27 125.35q-4.904 0-7.869-3.557-2.964-3.61-2.964-10.132 0-4.258 1.563-7.33 1.617-3.126 4.204-4.796 2.64-1.671 5.605-1.671 2.264 0 3.934.808 1.671.809 3.396 2.21l-.216-4.473V86.33h4.473v38.373h-3.664l-.378-3.072h-.161q-1.51 1.509-3.557 2.64-2.048 1.079-4.366 1.079zm.97-3.719q3.45 0 6.683-3.61v-13.69q-1.67-1.509-3.234-2.102-1.509-.646-3.126-.646-2.101 0-3.826 1.293-1.67 1.24-2.695 3.503-1.024 2.21-1.024 5.228 0 4.689 1.886 7.384 1.887 2.64 5.336 2.64zM926.96 125.35q-4.904 0-7.869-3.557-2.964-3.61-2.964-10.132 0-4.258 1.563-7.33 1.617-3.126 4.204-4.796 2.64-1.671 5.605-1.671 2.264 0 3.934.808 1.671.809 3.396 2.21l-.216-4.473V86.33h4.473v38.373h-3.664l-.378-3.072h-.161q-1.51 1.509-3.557 2.64-2.048 1.079-4.366 1.079zm.97-3.719q3.45 0 6.683-3.61v-13.69q-1.67-1.509-3.234-2.102-1.509-.646-3.125-.646-2.102 0-3.827 1.293-1.67 1.24-2.695 3.503-1.024 2.21-1.024 5.228 0 4.689 1.887 7.384 1.886 2.64 5.335 2.64zM958.54 125.35q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743t-1.67-7.33q0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.959 2.156-2.155 2.102-2.587 5.982zM985.01 125.35q-3.45 0-6.252-1.617-2.802-1.617-4.42-4.689-1.616-3.072-1.616-7.383 0-4.42 1.725-7.492 1.778-3.072 4.635-4.688 2.91-1.617 6.251-1.617 2.587 0 4.42.916 1.886.916 3.233 2.156l-2.263 2.91q-1.132-1.024-2.425-1.67-1.24-.647-2.803-.647-2.371 0-4.258 1.293-1.832 1.24-2.91 3.557-1.024 2.264-1.024 5.282 0 4.473 2.21 7.276 2.263 2.748 5.874 2.748 1.833 0 3.396-.754 1.563-.809 2.748-1.887l1.94 2.965q-1.778 1.563-3.934 2.479-2.156.862-4.527.862zM999.23 124.7V98.507h4.42V124.7zm2.264-31.582q-1.294 0-2.156-.755-.809-.808-.809-2.155 0-1.294.809-2.102.862-.809 2.156-.809 1.293 0 2.101.809.863.808.863 2.102 0 1.347-.862 2.155-.809.755-2.102.755zM1019.3 125.35q-2.803 0-5.336-1.024-2.533-1.078-4.419-2.587l2.21-2.964q1.724 1.347 3.557 2.263 1.832.863 4.15.863 2.587 0 3.88-1.186 1.293-1.24 1.293-2.91 0-1.348-.916-2.264-.862-.916-2.263-1.509-1.348-.647-2.803-1.185-1.832-.701-3.61-1.563-1.78-.917-2.911-2.318-1.132-1.455-1.132-3.665 0-3.18 2.371-5.281 2.426-2.156 6.683-2.156 2.426 0 4.528.862 2.101.862 3.61 2.102l-2.155 2.803q-1.348-1.024-2.803-1.671-1.455-.647-3.18-.647-2.479 0-3.664 1.132-1.132 1.132-1.132 2.64 0 1.24.808 2.049.809.754 2.102 1.347 1.294.539 2.749 1.132 1.886.7 3.718 1.617 1.833.862 3.019 2.371 1.24 1.455 1.24 3.934 0 2.102-1.133 3.88-1.078 1.78-3.233 2.857-2.102 1.078-5.228 1.078zM1035.1 124.7V98.507h4.42V124.7zm2.264-31.582q-1.294 0-2.156-.755-.809-.808-.809-2.155 0-1.294.809-2.102.862-.809 2.156-.809t2.101.809q.863.808.863 2.102 0 1.347-.863 2.155-.808.755-2.101.755zM1058.5 125.35q-3.18 0-5.982-1.617-2.749-1.617-4.474-4.689-1.67-3.072-1.67-7.383 0-4.42 1.67-7.492 1.725-3.072 4.474-4.688 2.802-1.617 5.982-1.617 3.234 0 5.982 1.617 2.749 1.616 4.42 4.688 1.724 3.072 1.724 7.492 0 4.311-1.724 7.383-1.671 3.072-4.42 4.69-2.748 1.616-5.982 1.616zm0-3.665q3.395 0 5.443-2.748 2.102-2.803 2.102-7.276 0-4.527-2.102-7.33-2.048-2.802-5.443-2.802-3.341 0-5.443 2.802t-2.102 7.33q0 4.473 2.102 7.276 2.101 2.748 5.443 2.748zM1077.5 124.7V98.507h3.665l.377 3.773h.162q1.886-1.887 3.988-3.126 2.102-1.294 4.797-1.294 4.15 0 6.036 2.641 1.94 2.587 1.94 7.6v16.6h-4.42v-16.008q0-3.665-1.185-5.335-1.186-1.671-3.773-1.671-1.994 0-3.61 1.024-1.564 1.024-3.558 3.018V124.7zM1113.9 125.35q-2.803 0-5.336-1.024-2.533-1.078-4.419-2.587l2.21-2.964q1.724 1.347 3.557 2.263 1.832.863 4.15.863 2.587 0 3.88-1.186 1.293-1.24 1.293-2.91 0-1.348-.916-2.264-.862-.916-2.263-1.509-1.348-.647-2.803-1.185-1.832-.701-3.61-1.563-1.78-.917-2.911-2.318-1.132-1.455-1.132-3.665 0-3.18 2.372-5.281 2.425-2.156 6.683-2.156 2.425 0 4.527.862 2.102.862 3.61 2.102l-2.155 2.803q-1.348-1.024-2.803-1.671-1.455-.647-3.18-.647-2.479 0-3.664 1.132-1.132 1.132-1.132 2.64 0 1.24.808 2.049.809.754 2.102 1.347 1.294.539 2.749 1.132 1.886.7 3.718 1.617 1.833.862 3.019 2.371 1.24 1.455 1.24 3.934 0 2.102-1.133 3.88-1.078 1.78-3.233 2.857-2.102 1.078-5.228 1.078zM1131.9 125.35q-1.347 0-2.317-.916-.917-.97-.917-2.426 0-1.562.917-2.479.97-.97 2.317-.97 1.294 0 2.21.97.97.916.97 2.48 0 1.455-.97 2.425-.916.916-2.21.916z"></path>
        </g>
        <g aria-label="Better health." fill="#a53995" stroke-width="3.368">
          <path d="M699.58 187.95v-35.355h10.509q3.61 0 6.306.862 2.748.863 4.257 2.749 1.563 1.886 1.563 5.012 0 2.64-1.347 4.797-1.294 2.102-3.827 2.91v.216q3.18.592 5.174 2.694 2.048 2.102 2.048 5.767 0 3.45-1.724 5.767-1.671 2.317-4.69 3.449-3.017 1.132-7.005 1.132zm4.473-20.318h5.228q4.527 0 6.521-1.563 1.994-1.563 1.994-4.258 0-3.072-2.101-4.365-2.048-1.294-6.198-1.294h-5.444zm0 16.761h6.144q4.581 0 7.114-1.67 2.533-1.725 2.533-5.282 0-3.288-2.533-4.797-2.479-1.563-7.114-1.563h-6.144zM741.46 188.6q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.072-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.659-1.67 5.012 0 7.706 3.341 2.75 3.342 2.75 8.947 0 .7-.055 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.617-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.796.808zm-8.246-15.845h14.013q0-3.988-1.724-6.036-1.671-2.102-4.743-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM765.28 188.6q-4.204 0-5.875-2.425-1.616-2.426-1.616-6.306v-14.498h-3.88v-3.341l4.095-.27.54-7.33h3.718v7.33h7.06v3.611h-7.06v14.552q0 2.425.862 3.773.916 1.293 3.18 1.293.7 0 1.51-.215l1.454-.486.863 3.342q-1.078.377-2.372.647-1.24.323-2.479.323zM782.42 188.6q-4.204 0-5.875-2.425-1.616-2.426-1.616-6.306v-14.498h-3.88v-3.341l4.095-.27.54-7.33h3.718v7.33h7.06v3.611h-7.06v14.552q0 2.425.862 3.773.916 1.293 3.18 1.293.7 0 1.51-.215l1.454-.486.863 3.342q-1.078.377-2.372.647-1.24.323-2.479.323zM802.25 188.6q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.072-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.562 2.91q-1.67 1.078-3.826 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM818.36 187.95v-26.193h3.665l.377 4.743h.162q1.347-2.48 3.287-3.935t4.15-1.455q1.563 0 2.803.54l-.863 3.88q-.646-.216-1.185-.324t-1.348-.108q-1.67 0-3.503 1.348-1.778 1.347-3.126 4.689v16.815zM847.84 187.95v-38.373h4.42v10.456l-.162 5.39q1.886-1.779 3.934-3.019 2.102-1.293 4.797-1.293 4.15 0 6.036 2.64 1.94 2.588 1.94 7.6v16.6h-4.42v-16.007q0-3.665-1.185-5.336-1.186-1.67-3.773-1.67-1.994 0-3.61 1.024-1.564 1.024-3.558 3.018v18.97zM887.78 188.6q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.072-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.659-1.67 5.012 0 7.706 3.341 2.75 3.342 2.75 8.947 0 .7-.055 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.617-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.796.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.959 2.156-2.155 2.102-2.586 5.982zM909.18 188.6q-3.288 0-5.497-1.94-2.156-1.994-2.156-5.498 0-4.311 3.826-6.575 3.88-2.317 12.234-3.233 0-1.671-.485-3.18-.43-1.51-1.616-2.426-1.132-.97-3.288-.97-2.264 0-4.258.863-1.994.862-3.557 1.94l-1.724-3.072q1.832-1.186 4.473-2.264 2.695-1.131 5.82-1.131 4.797 0 6.953 2.964 2.156 2.91 2.156 7.814v16.061h-3.665l-.377-3.125h-.162q-1.832 1.509-4.042 2.64-2.156 1.132-4.635 1.132zm1.294-3.557q1.886 0 3.556-.916 1.671-.916 3.557-2.587v-7.276q-6.52.808-9.162 2.425-2.587 1.617-2.587 4.15 0 2.21 1.348 3.234 1.347.97 3.287.97zM934.99 188.6q-2.48 0-3.61-1.509-1.079-1.563-1.079-4.42v-33.09h4.42v33.415q0 1.024.377 1.509.377.43.862.43h.377q.216-.053.593-.107l.593 3.341q-.431.216-1.024.324-.593.108-1.509.108zM952.29 188.6q-4.204 0-5.875-2.425-1.616-2.426-1.616-6.306v-14.498h-3.88v-3.341l4.095-.27.54-7.33h3.718v7.33h7.06v3.611h-7.06v14.552q0 2.425.862 3.773.916 1.293 3.18 1.293.7 0 1.51-.215l1.454-.486.863 3.342q-1.078.377-2.372.647-1.24.323-2.479.323zM962.26 187.95v-38.373h4.42v10.456l-.162 5.39q1.886-1.779 3.934-3.019 2.102-1.293 4.797-1.293 4.15 0 6.036 2.64 1.94 2.588 1.94 7.6v16.6h-4.42v-16.007q0-3.665-1.185-5.336-1.186-1.67-3.773-1.67-1.994 0-3.61 1.024-1.564 1.024-3.558 3.018v18.97zM993.9 188.6q-1.347 0-2.317-.916-.917-.97-.917-2.426 0-1.563.916-2.479.97-.97 2.318-.97 1.294 0 2.21.97.97.917.97 2.48 0 1.455-.97 2.425-.917.916-2.21.916z"></path>
        </g>
      </svg>
    </div>
    <h1>Supplementary material 33 to: Daily iron supplementation for prevention or treatment of iron deficiency anaemia in infants, children, and adolescents</h1>
    <p>
      <span class="byline">Rajagopalan K, Hackl L, Pe&ntilde;a-Rosas JP, Garcia-Casal MN, Rizal M, Mehta NH, Roudik M, Islam S, Trumbull-Kennedy MM, Khondakar NR, Franco JVA, Finkelstein JL, Mehta S</span>
      <br>
      <span class="doi"><a href="https://doi.org/10.1002/14651858.CD013227.pub2">https://doi.org/10.1002/14651858.CD013227.pub2</a></span>
    </p>
    <p>
      <span class="disclaimer">The material in this section has been supplied by the author(s) for publication under a Licence for Publication and the author(s) are solely responsible for the material. Cochrane has reviewed this material, but Cochrane has not copyedited, formatted or proofread. Cochrane accordingly gives no representations or warranties of any kind in relation to, and accepts no liability for any reliance on or use of, such material.</span>
    </p>
    <div id="backToTop">
      <a href="#top">Back to top</a>
    </div>
    <h1>Description of interventions_9</h1>
    <div>
      <table>
        <tr>
          <th style="vertical-align: top;">
            <p>Item</p>
          </th><th style="vertical-align: top;">
            <p>Study ID</p>
          </th>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td style="vertical-align: top;">
            <p>Buzina-Suboticanec 1998</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td style="vertical-align: top;">
            <p>"Effects of iron supplementation of iron nutrition status and cognitive functions in children"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td style="vertical-align: top;">
            <p>"Children from an elementary school near Zagreb with a relatively high prevalence of mild anaemia...attending the third grade of elementary education and between 8.7 and 9.6 years of age were selected."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td style="vertical-align: top;">
            <p>"Iron deficiency at any age has been shown to have adverse effects on cognitive performance [<a href="#421722979723135028">1</a>], with the response to iron supplementation depending on the circumstances&hellip;The present study is significant because it demonstrates that even in a relatively well-nourished population, at least with normal weight-for-age, iron deficiency still has a highly significant effect on cognitive performance that can be corrected by iron supplementation."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td style="vertical-align: top;">
            <p>"All children received initial anthropometric, biochemical,and psychological examinations to collect baseline pre-treatment data&hellip;All examinations were repeated after 10 weeks of supplementation&hellip;<br>
              <br> Anthropometric examinations included measurements of body weight, body height, and bicipital, tricipital, subscapular, and midaxillary skinfolds. On the basis of weight and height measurements, the relative bodyweight (weight as percentage of standard weight-for-height) as a criterion of current nutrition status and the relative body height (percentage of standard height-for-age) as a criterion of growth performance were calculated. Relative body weight and relative body height were calculated using National Center for Health Statistics data as the reference standard [<a href="#421727411220532100">2</a>]. The percentage of body fat was calculated from skinfold measurements according to the equation of Durnin and Rahaman [<a href="#421727427575958405">3</a>].<br>
              <br> Venous blood (20 ml) was drawn from each subject using disposable plastic needles and syringes. Approximately 3 ml of the whole blood was placed into anEDTA-containing tube for blood cell counts and other haematological examinations. An equal amount of the whole blood was mixed with acid citrate dextrose stabilizer containing 7.3 g/L citric acid, 22.0 g/L sodium anhydride, and 24.5 g/L D-glucose monohydrate for the enzymatic determination of thiamine, riboflavin,and pyridoxine in the red blood cells. The remaining blood was allowed to clot, and 0.5 ml of serum was separated and mixed with 4.5 ml of 5% meta phosphoric acid. This sample and the rest of the serum were frozen at -30&deg;C for further analyses. All blood samples were drawn between 8 and 10 a.m. Iron status was assessed by measuring haemoglobin, haematocrit, and red blood cell count (RBC) and by calculating mean corpuscular haemoglobin (MCH), mean corpuscular volume (MCV), and mean corpuscular haemoglobin concentration (MCHC) using standard automated blood-cell counter procedures and the ABX-ARGOS counter (Roche). Serum iron and total iron-binding capacity (TIBC) were measured by the ferrozine method [<a href="#421727456636980104">4</a>] and Spectrum autoanalyser (Abbot, Irving, Tex, USA), and transferrin saturation was calculated as the ratio of serum iron to TIBC &times; 100. In addition, the following biochemical values were measured: vitamins A and E in serum by high-performance liquid chromatography [<a href="#421727485894871946">5</a>] and vitamin C in serum by a modification of the fluorometric method of Brubacher and Vuilleumier [<a href="#421727533191416716">6</a>]. Erythrocyte thiamine was determined on the basis of transketolase enzyme reactivation (ETK), erythrocyte riboflavin on the basis of the glutathione reductase reactivation test (EGR), and erythrocyte pyridoxine on the basis of glutamic oxalacetic transaminase (EGOT) reactivation [<a href="#421740788742904649">7</a>, <a href="#421727612293368740">8</a>]. Zinc in serum was measured by atomic absorption spectrophotometry [<a href="#421727649960053670">9</a>]...<br>
              <br> Cognitive function was assessed between 8 a.m. and noon Monday through Saturday, with children from each class examined on alternate days. The testing was done in a separate, quiet room in the school library with which the children were familiar. The environment was comfortable and free of distraction. The abbreviated Wechsler Intelligence Scale for Children-Revised (WISC-R) containing six subtests&mdash;arithmetic, similarities, digit span, picture completion, block design, and digit symbol (coding)&mdash;was used to obtain information on both verbal and non-verbal aspects of intelligence in individual subjects. In the coding test, children have to substitute symbols for numbers as quickly as possible. The score represents the total number of correct symbols written during a fixed time.</p>
            <p>
              <br> The coding test primarily assesses visual-motor coordination, visual encoding, and short-term memory, concentration, and sustained attention. The arithmetic test involves primary mental arithmetic problems, each having a time limit. The scores represent the total number of correct answers.</p>
            <p>
              <br> The arithmetic test primarily assesses numerical reasoning, concentration, verbal comprehension and integration, and knowledge of basic numerical operations. Other factors influencing performance are short-term memory, attention, and interest in and comfort with mathematics.</p>
            <p>
              <br> The similarities test is composed of 13 questions inquiring how the concepts are related to each other. It is considered to reflect logical abstract (categorical) thinking and verbal concept formation. Other factors influencing performance are long-term memory, concentration, and cultural experience.The digit-span test involves the immediate recall of increasingly longer strings of digits that are read to the children. One set has to be recalled forward as they are given and a second set has to be recalled backwards.The forward and backward items were analysed separately, and the children&rsquo;s scores represent the total number of correct responses. This test measures attention, short-term auditory memory, and auditory sequencing .</p>
            <p>
              <br> In picture completion, the subject is asked to find the missing parts in a picture. The test is said to reflect visual alertness as well as visual recognition and identification (long-term visual memory).</p>
            <p>
              <br> In block design, the subject is required to copy a sample design using cubes painted in different colours and patches. This test breaks down the analysis of the whole into its component parts&mdash;nonverbal concept formation and spatial visualization."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td style="vertical-align: top;">
            <p>"...tablets were distributed...under the supervision of the teachers. The school health nurse visited classes and teachers twice a week"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td style="vertical-align: top;">
            <p>teacher administration</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td style="vertical-align: top;">
            <p>"...elementary school near Zagreb"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td style="vertical-align: top;">
            <p>"...from one class (supplemented group) were then given tablets for 10 weeks containing 100 mg of iron in the form of ferri-glycine sulfate (Orferon Retard-Pliva, Zagreb),</p>
            <p>while children from the other class (control group) received placebo tablets identical in appearance."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"The tablets were distributed daily, except Sunday, in a double-blind manner under the supervision of the teachers...The school health nurse visited classes and teachers twice a week in order to confirm compliance with the distribution"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>Rosado 1997</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>Effects of iron and zinc supplementation on growth and haematological outcomes in children </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>Children between 18 and 36 months of age.</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"In rural Mexico and in many developing countries micronutrient deficiencies, growth stunting, and morbidity from infectious diseases are highly prevalent in young children. We assessed the extent to which growth stunting could be reversed and the number of infectious disease episodes reduced by zinc and/or iron supplementation." </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>&mdash;<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Anthropometric data were collected at baseline (before supplementation) and within 2 wk after 6 and 12 mo of supplementation. Measurements on all three occasions were performed by the same examiner (PL) following standard procedures [<a href="#421741042645883725">10</a>]. Measures included weight to 0.1 kg on a pediatric scale, standing height to 0.1 cm with an anthropometer, midupper arm circumference (MAC) to 0.1cm by using a fiberglass tape measure on the left arm, and triceps skinfold thickness accurate to 0.1 mm by using a Lange skinfold caliper...<br> Z scores were calculated from National Center for Health Statistics (NCHS) reference values for weight and height [<a href="#421741100637117265">11</a>] Midarm fat area (MAFA) and midarm muscle area (MAM) were derived from MAC and triceps-skinfold-thickness measurements [<a href="#421741242276928344">12</a>]...<br>
              <br> A clinical exam was conducted by a physician in the field clinic at baseline and at 6 and 12 mo after supplementation. Data collected during this exam included signs of nutrient deficiencies or other diseases. Any current diseases received appropriate treatment...Morbidity of the preschoolers was evaluated twice weekly by a questionnaire administered by a trained fieldworker who visited the child at home Information was obtained from the child's mother about the presence or absence of illness on the day of the visit and since the previous visit. Any illness was recorded by the fieldworker on a precoded list that included the most common diseases and their symptoms, as well as the date when symptoms started and the date when they disappeared. When the fieldworker had any doubt about the diagnosis or course of the disease, the physician in charge of the field clinic visited the child to confirm the diagnosis...symptoms classified by a physician into the following categories; upper and lower respiratory disease...diiarrhea, fever, and "other. "Respiratory disease" was defined as having any symptom such as runny nose, common cold, sore throat, or cough."Diarrhea" was defined by the mothers based on their observation of frequent, loose stools...<br>
              <br> A 2-mL sample of venous blood was collected from every preschooler at baseline and at 6 and 12 mo after supplementation. After the children had fasted overnight, blood samples were collected in an evacuated container and transferred to a tube that contained 0.05 mL sodium citrate as an anticoagulant. Duplicate hemoglobin and hematocrit determinations were performed within 3 h of blood collection. Hemoglobin was determined by using a Coulter counter (Coulter Electronics, Hialeah, FL). Plasma and red blood cells were dispensed as aliquots and frozen at &mdash;70 &deg;C until analyzed. Plasma zinc was determined in duplicate by atomic absorption spectrophotometry, and plasma ferritin was measured by using a solid-phase radioimmunoassay (Coat-A-Count Ferritin IRMA; Diagnostic Products, Los Angeles) and an international standard obtained from the World Health Organization Internal Laboratory for Biological Standards (National Institute of Biological Standards and Control, Hertsfordshire, United Kingdom). To detect infections of inflammation, plasma C-reactive protein (CRP) was measured by a Behring laser nephelometer after adding antiserum for CRP (Behring Diagnostics, Inc, Somerville, NJ); a protein control serum was included in the test (Behring Diagnostics, Inc.)." </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Anthropometric data ...were performed by the same examiner (PL) following standard procedures...A clinical exam was conducted by a physician in the field clinic...Morbidity...was evaluated twice weekly<br> by...trained fieldworker...When the fieldworker had any doubt about the diagnosis or course of the disease, the physician in charge of the field clinic visited the child to confirm the diagnosis...symptoms classified by a physician" </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>home-visits by a fieldworker<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Valley of Sol&iacute;s, a rural region in central Mexico...five rural communities" </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"...four groups received a daily supplement consisting of 20 mL of solution containing either</p>
            <p>20 mg elemental Zn as zinc methionine,</p>
            <p>20 mg Fe as ferrous sulfate,</p>
            <p>20 mg Zn + 20 mg Fe, or</p>
            <p>a placebo (solution alone)&hellip;This solution contained sugar, citric acid, water, and artificial flavor (either orange or lemon)...Children in each group received the supplements for 12 mo." </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"The flavor of the supplement (lemon or orange) was changed every week to improve compliance." </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"They were visited in their homes from Monday through Friday by a fieldworker who gave the supplement and ensured that it was completely consumed in her presence."<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Compliance was excellent; the supplements were consumed on average on 97% of the days they were administered." </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>Mitra 1997<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>Effects of long-term oral iron supplementation on morbidity in Bangladeshi children</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"The study included infants and children aged 2 to 48 mo of either sex and excluded children who were critically ill or who had evidence of congenital malformation or metabolic disorders&hellip;living in a poor community of Bangladesh"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"The unresolved debate of iron and morbidity prompted us to evaluate the effect of iron supplementation on morbidity in children through a controlled prospective study."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"...daily for 15 mo...one teaspoon of syrup (5 mL) containing 125 mg of ferrous gluconate (15 mg elemental iron) plus vitamins or vitamins only to their children every day immediately before breakfast...Measures of weight and length (standing height in children &gt; 24mo old) were taken once a month, and morbidity was recorded on alternate days. Body weight was measured using a balance (Seca,Germany) with a precision of 20 g, and length was measured using a locally constructed length board with a precision of 0.1 cm."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"House-to-house visits were made...by trained community health workers for recording symptoms and duration of illnesses and for monitoring medicine intake&hellip;Mothers were advised to administer&hellip;Compliance to the protocol was monitored by trained community health workers (one for each household cluster)...Two study physicians attended the weekly clinic and provided treatment for the patients...The investigators made unscheduled spot visits to monitor the activities of the workers. At these visits, problems encountered were discussed and advice made accordingly. Health assistants supervised the volunteers and summarized the daily records."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Mothers were advised to administer"<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"...peri-urban slum village of Nandipara, about 10 km northeast of Dhaka, Bangladesh" </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"...daily for 15 mo...one teaspoon of syrup (5 mL) containing 125 mg of ferrous gluconate (15 mg elemental iron) plus vitamins or vitamins only to their children every day immediately before breakfast."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"House-to-house visits were made on alternate days by trained community health workers...for monitoring medicine intake&hellip;Health workers visited assigned houses daily and recorded the amount of medicine taken by checking and returning the empty bottles to the clinic."<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"A total of 349 children aged 2&ndash;48 mo were enrolled. Forty children (20 in each group) dropped out of the study, and 152 in the iron group nd 157 controls remained in the study. Seventy-three percent (111 of 152) children in [sic] iron group and 78% (123 of 157) controls continued [sic] supplement for 1 y or more...Seventy-six percent of the children continued the syrup for over 1 y&hellip;On average, the children consumed 80% (4 mL) of the dose." </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td style="vertical-align: top;">
            <p>Lee 1997</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td style="vertical-align: top;">
            <p>Effect of Vitamin C Supplementation on Iron Status of Adolescent Girls with Low Hemoglobin Levels</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td style="vertical-align: top;">
            <p>"female adolescent students of a middle school in a rural area participated in this study. They ranged in age from 12 - 15 years and had experienced menstruation for more than 6 months. All of them were apparently healthy"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td style="vertical-align: top;">
            <p>"in order to investigate the hematologic response to the vitamin C supplementation at three daily meals of 50mg or 300mg per meal"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td style="vertical-align: top;">
            <p>"150mg vitamin C as L-ascorbic acid(AsA, coated, USP)...50mg each as a tablet"; "900mg AsA...in the same way as C-150"; "60mg of iron as ferrous sulfate was given in the same way as C-150"; "sugar placebo"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td style="vertical-align: top;">
            <p>"The subjects were randomly divided into four groups - 9, 9, 9, and 8 subjects for Group I, II, III, and IV, respecitvely. Group I(C-150) received 150mg vitamin C as L-ascorbic acid(AsA, coated, USP) daily, given in three doses of 50mg each as a tablet one hour after each meal, for a period of 9 weeks. Group II(C-900) received 900mg AsA daily in the same way as in C-150. To group III(Fe-60) a daily 60mg of iron as ferrous sulfate was given in the same way as in C-150 for the comparison between iron and AsA supplementing effects on body iron status. Group IV(Placebo) was given sugar placebo."; "During the trial period subjects continued with their usual diets and daily activities."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td style="vertical-align: top;">
            <p>tablet; individual</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td style="vertical-align: top;">
            <p>"middle school in a rural area"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td style="vertical-align: top;">
            <p>"The subjects were randomly divided into four groups - 9, 9, 9, and 8 subjects for Group I, II, III, and IV, respecitvely. Group I(C-150) received 150mg vitamin C as L-ascorbic acid(AsA, coated, USP) daily, given in three doses of 50mg each as a tablet one hour after each meal, for a period of 9 weeks. Group II(C-900) received 900mg AsA daily in the same way as in C-150. To group III(Fe-60) a daily 60mg of iron as ferrous sulfate was given in the same way as in C-150 for the comparison between iron and AsA supplementing effects on body iron status."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td style="vertical-align: top;">
            <p>Berger 1997</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td style="vertical-align: top;">
            <p>Weekly iron supplementation is as effective as 5 day per week iron supplementation in Bolivian school children living at high altitude</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td style="vertical-align: top;">
            <p>"Subjects were healthy children of both sexes, aged 3.3-8.3 y, attending the schools administered by the Non-Governmental Organization `Fe y Alegria'."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td style="vertical-align: top;">
            <p>"To compare the eficacy of a daily and a weekly iron supplementation on the hematological status of anemic children living at high altitude."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td style="vertical-align: top;">
            <p>"Hemoglobin Photometer HemoCue (HemoCue AB, Angelholm, Sweden) and the zinc erythrocyte protoporphyrin using a hematofluorometer (AVIV Biomedical, model 206)"; "electronic scale (TEFAL, France)"; tablets</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td style="vertical-align: top;">
            <p>"Out of 260 children measured, 176 (67.7%) had a hemoglobin concentration of &le; 144 g/L. These 176 children were randomly assigned to three groups:</p>
            <p>(1) Control group (58 children) received a placebo, once a week, every Tuesday;</p>
            <p>(2) Group 1 (59 children) received a dose or iron, once a week, every Tuesday;</p>
            <p>(3) Group 2 (59 children) received a daily dose of iron, 5 d per week, Monday to Friday."; "Hemoglobin screening was performed at the beginning of the study (T0), tablet administration for selected children started the following day. Hemoglobin concentration was determined again 5 weeks (T5), 10 weeks (T10) and 16 weeks (T16) after the beginning of the study whereas the zinc erythrocyte protoporphyrin concentration was determined only at T0 and T16. At the end of the study, all children still anemic were supplemented. Iron supplements were given to the mothers taught to give the supplement to their children 5 d per week, Monday to Friday. Standard anthropometric assessment was performed by a trained member of the team both at T0 and T16."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td style="vertical-align: top;">
            <p>"The tablets were given to children at school, with clean boiled water, at mid-morning (one and a half hours after breakfast and one and a half hours before lunch), by trained school assistants, under the supervision of a member of the research team."; "a trained member of the team"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td style="vertical-align: top;">
            <p>tablets; individual</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td style="vertical-align: top;">
            <p>"the schools administered by the Non-Governmental Organization `Fe y Alegria'."; "A socioeconomically disatvantaged district of La Paz, Bolivia (altitude of 4000 m)."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td style="vertical-align: top;">
            <p>"(1) Control group (58 children) received a placebo, once a week, every Tuesday;</p>
            <p>(2) Group 1 (59 children) received a dose or iron, once a week, every Tuesday;</p>
            <p>(3) Group 2 (59 children) received a daily dose of iron, 5 d per week, Monday to Friday."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td style="vertical-align: top;">
            <p>"The supplement consisted of two types of tablets of similar size and aspect, made mainly of lactose, containing either 20 mg or 36 mg of elemental iron in form of FeSO4 (IFA Laboratories, Santa Cruz, Bolivia) used in combination to adjust the dose for the child's weight"; "At the end of the study, all children still anemic were supplemented. Iron supplements were given to the mothers taught to give the supplement to their children 5 d per week, Monday to Friday."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"The tablets were given to children at school, with clean boiled water, at mid-morning (one and a half hours after breakfast and one and a half hours before lunch), by trained school assistants, under the supervision of a member of the research team."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"A complete data set was obtained for<br> 57 children of the control group and 58 children for both<br> groups 1 and 2. Children were 3.3&plusmn;8.3 y old but 96.3% of<br> them were between 4.0&plusmn;6.9 y old. Only 3 children (1 boy<br> and 2 girls) dropped out during the study, one in each group<br> (initial hemoglobin: 135, 136, 143 g/L respectively for the<br> children from the placebo group, group 1 and group 2).<br> Dropouts were due to migration of the family out of the<br> area of study."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>Northrop-Clewes 1996</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Effect of improved vitamin A status on response to iron supplementation in Pakistani infants" </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"...breast-fed infants &lt; 2 y of age" </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"We report observations on some indexes of the acute-phase response in infants after a double-blind iron-supplementation study and also an apparent influence of vitamin A status on these changes&hellip;Because of the possibility that iron may increase morbidity, the objective of our investigation was to examine the changes in acute-phase proteins after iron supplementation for evidence of increased acute-phase activity."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>&mdash;<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Venous blood was taken after supplementation...venous Blood (2-3 mL) was collected...into EDTA [ethylenediaminetetraacetic acid]-coated evacuated tubes (Becton Dickinson, Cowley, UK)...After collection, blood was placed in an ice just chest for not longer than 3 h. Samples were then transferred to the laboratory (3-4 km away), where hemoglobin was measured with a HemoCue haemoglobinometer [<a href="#421741367020510042">13</a>]. Plasma was separated and stored at -20 &deg;C before analysis of plasma ferritin... through use of radioimmunoassay [<a href="#421741387201665884">14</a>]. Plasma samples from before and after supplementation...analyzed for retinal and alpha-tocopherol and for determination of a carotene profile with HPLC [<a href="#421741420403776350">15</a>]. in this system, lutein elutes as a combined peak with zeaxanthin. The acute-phase proteins , alpha-1 cantichymotrypsin (ACT), ceruloplasmin, and albumin and immunolglobulin (Ig) A, IgG and IgM were analyzed with immunoprecipitation techniques (Dako LTd. High Wycombe, UK) on a Cobas Fara analyzer (Roche Diagnostics, Welwyn, UK)."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"...health visitors and guide women" </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>&mdash;<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"...area &asymp;20 km northeast of Peshawar, Pakistan" </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"...treatment group was given 15 mg iron orally as ferrous sulfate (FeSO<sub>4</sub>, sorbitol-based aqueous solution; Abbot Laboratory, Pakistan) on a daily basis,</p>
            <p>the control group received a placebo (taste-matched by the Institute for International Development, Boston)."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>&mdash;<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>&mdash;<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Compliance was ensured by. Health visitors and guide women who gave the solutions each day."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>&mdash;<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>Lozoff 1996 </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>Effects of iron supplementation on developmental test scores in infants </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"...non-anaemic infants...from the periurban community of Desamparados...near San Jose, the capital of Costa Rica...predominantly lower middle class...12- to 23-month-old infants" </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"To determine whether extended oral iron therapy corrects lower developmental test scores in infants with iron-deficiency anemia." </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>&mdash;<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"The Bayley Scales of Infant Development [<a href="#421723125860288599">16</a>] were administered before and after both 3 months and 6 months of oral iron or placebo treatment. A physical examination and a venipuncture blood specimen were also repeated after 3 and 6 months to monitor the children's health and their hematologic response to iron therapy. Comprehensive information was collected about the child and family, including demography, birth history, nutrition, socioeconomic status, stimulation in the home (HOME Inventory, [<a href="#421742670737072849">17</a>]), and parental IQ." </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Project personnel personally administered the dose of iron or placebo three times per week and recorded the times that the remaining doses of medication were given by family members." </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>individual administration<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Hospital Nacional de Ni&ntilde;os"<br>  
              <br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"...oral iron preparation (3 mg/kg per dose) or</p>
            <p>placebo drops (a similar volume of carder alone) twice a day for 6 months" </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"All anemic infants received orally administered iron twice a day (3 mg/kg per dose) for 6 months."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>&mdash;<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>&mdash;<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"During the 6 months of study participation, 6% dropped out (5 children: 4 nonanemic, 1 anemic), primarily because of moving out of the community."<br>  
            </p>
          </td>
        </tr>
      </table>
    </div>
    <div>
      <table>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>Bruner 1996 </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls" </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"...girls who enrolled at the four schools (grades 9&mdash;12 [ages 13&mdash;18])&hellip;with non-anaemic iron deficiency" </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"...a better understanding of the possible cognitive effects of iron deficiency in the absence of anaemia is particularly important because of the high rate of this condition in adolescent girls. The main of this randomised, double-blind, placebo-controlled trial was to examine the effects of iron supplementation on attention, memory, and learning in non-anaemic iron-deficient adolescent girls." </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"...an explanatory letter and consent form were sent to all girls who attended the schools, and distributed at school open-houses and in science and health classes."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"voluntary screening for iron deficiency, which consisted of a complete blood count and measurement of serum ferritin concentration&hellip;Students completed a brief demographic and medical history questionnaire before blood samples were taken at the school by venepuncture. Haemoglobin concentrations were obtained from a complete blood count, and serum ferritin was measured by chemiluminometric immunoassay (CIBA Corning Ciagnostic Corporation, Norwood, Massachusetts, USA). All laboratory tests were done by SmithKline Beecham Clinical Laboratories...After randomisation, baseline cognitive functioning was assessed. Standard cognitive test were administered by trained research assistants at the participants' schools; three measures of attention and one multicomponent test of verbal learning and memory were used."</p>
            <p>Brief Test of Attention [<a href="#421741576699011675">18</a>]: measure of auditory divided attention - participants listen to a tape of letters/numbers and report how many numbers or letters they hear.<br>
              <br> "Symbol Digit Modalities Test (SDMT, [<a href="#421741595884806753">19</a>]) is a timed measure of visual attention, motor speed, and rapid coding - participants print a number that corresponds to a written symbol listed at the top of the test page and the task is repeated with the participant saying the digits...<br>
              <br> Visual Search Attention Test (VSAT, [<a href="#421741639007494789">20</a>]) is timed test of visual scanning, target detection, and cancellation in which participants locate and cross out letters or symbols that look like the target...<br>
              <br> Hopkins Verbal Learning Test (HVLT, [<a href="#421741660540002950">21</a>]) is a 12-item semantically categorised word-list learning test with three free recall trials, a delayed recall trial, and yes/no recognition; participants are read the same list of words three times and each time are asked to repeat as many words as they can recall, 20 min later they are asked to say which words they remember, and are read 24 words which include the original 12 words plus 12 semantically related and unrelated words...<br>
              <br> After treatment had stopped, haematological and cognitive tests were repeated and participants completed a brief questionnaire"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Research assistants administered one dose of treatment or placebo every schoolday; on weekends and holidays girls were&hellip;reminded to take their tablets&hellip;researchers worked closely with girls and their families" </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>&mdash;<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"...two public (ie, state-supported) high schools and two private Catholic high schools in Baltimore, Maryland, USA </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"...non-prescription ferrous sulphate preparation (Feosol, SmithKline Beecham) or placebo for 8 weeks. Two 325 mg tablets of ferrous sulphate were taken twice daily. equivalent to 260 mg elemental iron daily&hellip;Iron and placebo (SmithKline Beecham) tablets were identical in appearance and dose regimen."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>&mdash;<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"...ensured optimum compliance in several ways. Research assistants administered one dose of treatment or placebo every schoolday; on weekends and holidays girls were contacted at home and reminded to take their tablets. In addition, researchers worked closely with girls and their families to encourage continuing participation, monitor compliance, and ask about side-effects. Every week girls received their supply of tablets and were asked to report any doses that they had not taken. Finally, participants were given small prizes at school, which they could receive only at the time scheduled for that day's regimen." </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Of the 81 girls who enrolled, 78 (96%) completed the intervention (two girls transferred to other schools, one withdrew on the first day of the intervention)" </p>
          </td>
        </tr>
        <tr>
          <td colspan="2" style="vertical-align: top;">
            <p>
              <b>ACT</b>:<b> </b>-1 antichymotrypsin; <b>CRP</b>: C-reactive protein; <b>d</b>: day(s);<b> Fe</b>: iron; <b>FeSO<sub>4</sub></b>: ferrous sulphate; <b>EDTA</b>: ethylenediaminetetraacetic acid; <b>HVLT</b>: Hopkins Verbal Learning Test; <b>Ig</b>: immunoglobulin; <b>MAC</b>: midupper arm circumference; <b>MAM</b>: midarm muscle area; <b>MAFA</b>: midarm fat area; <b>MCH</b>: mean corpuscular haemoglobin; <b>MCHC</b>: mean corpuscular haemoglobin concentration; <b>mo</b>: month(s); <b>MCV</b>: mean corpuscular volume; <b>mo</b>: months; <b>NCHS</b>: National Center for Health Statistics; <b>NCHS</b>: National Center for Health Statistics; <b>RBC</b>: red blood cell; SDMT: Symbol Digit Modalities Test; <b>TIBC</b>: total iron-binding capacity;<b> wk</b>: week(s);<b> VSAT</b>: Visual Search Attention Test; <b>WISC-R</b>: Wechsler Intelligence Scale for Children-Revised; <b>y</b>: year(s); <b>Zn</b>: zinc.</p>
            <p>&mdash;: denotes not reported</p>
          </td>
        </tr>
      </table>
    </div>
    <h2>References</h2>
    <ol>
      <li id="421722979723135028">
        <span publication-type="journal"><span person-group-type="author"><span><span>Lozoff</span> <span>B</span></span>, <span><span>Brittenham</span> <span>GM</span></span></span>. <span>Behavioral aspects of iron deficiency</span>. <span>Progress in Hematology</span> <span>1986</span>;<span>14</span>:<span>23-53</span>.</span>
      </li>
      <li id="421727411220532100">
        <span publication-type="other"><span person-group-type="author"><span>NCHS</span></span>. <span>NCHS growth charts</span>. <span>United States Public Health Service, HealthResources Administration</span> <span>1976</span>.</span>
      </li>
      <li id="421727427575958405">
        <span publication-type="journal"><span person-group-type="author"><span><span>Durnin</span> <span>JV</span></span>, <span><span>Rahaman</span> <span>MM</span></span></span>. <span>The assessment of the amount of fat in the human body from measurements of skinfold thickness</span>. <span>British Journal of Nutrition</span> <span>1967</span>;<span>21</span>(<span>3</span>):<span>681-9</span>. [DOI: <a href="https://doi.org/10.1079/BJN19670070">10.1079/BJN19670070</a>]</span>
      </li>
      <li id="421727456636980104">
        <span publication-type="journal"><span person-group-type="author"><span><span>Carter</span> <span>P</span></span></span>. <span>Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine)</span>. <span>Analytical Biochemistry</span> <span>1971</span>;<span>40</span>(<span>2</span>):<span>450-8</span>. [DOI: <a href="https://doi.org/10.1016/0003-2697(71)90405-2">10.1016/0003-2697(71)90405-2</a>]</span>
      </li>
      <li id="421727485894871946">
        <span publication-type="journal"><span person-group-type="author"><span><span>Vuilleumier</span> <span>JP</span></span>, <span><span>Keller</span> <span>ME</span></span>, <span><span>Gysel</span> <span>D</span></span>, <span><span>Hunziker</span> <span>F</span></span></span>. <span>Clinical chemical methods for the routine assessment of the vitamin status in human populations. Part I: The fat-soluble vitamins A and E, and beta-carotene</span>. <span>International Journal for Vitamin and Nutrition Research</span> <span>1983</span>;<span>53</span>:<span>265-72</span>. [PMID: <a href="https://www.ncbi.nlm.nih.gov/pubmed/6685115">6685115</a>]</span>
      </li>
      <li id="421727533191416716">
        <span publication-type="book"><span person-group-type="author"><span><span>Brubacher</span> <span>G</span></span>, <span><span>Vuilleumier</span> <span>JP</span></span></span>. <span>Clinical Biochemistry: principles and methods</span>. Vol. <span>1</span>. <span>New York, Berlin</span>: <span>de Gruyter</span>, <span>1974</span>. </span>
      </li>
      <li id="421740788742904649">
        <span publication-type="journal"><span person-group-type="author"><span><span>Vuilleumier</span> <span>JP</span></span>, <span><span>Keller</span> <span>ME</span></span>, <span><span>Retenmaier</span> <span>R</span></span>, <span><span>Hunziker</span> <span>F</span></span></span>. <span>Clinical chemical methods for the routine assessment of the vitamin status in human populations. Part II: The water-soluble vitamins B1, B2 and B6</span>. <span>International Journal for Vitamin and Nutrition Research</span> <span>1983</span>;<span>53</span>:<span>359-70</span>. [PMID: <a href="https://www.ncbi.nlm.nih.gov/pubmed/6668136">6668136</a>]</span>
      </li>
      <li id="421727612293368740">
        <span publication-type="journal"><span person-group-type="author"><span><span>Vuilleumier</span> <span>JP</span></span>, <span><span>Keller</span> <span>HE</span></span>, <span><span>Keck</span> <span>E</span></span></span>. <span>Clinical chemical methods for the routine assessment of the vitamin status in human populations. Part III: The apoenzyme stimulation test for vitamin B1, B2 and B6 adapted to the Cobas-Bio Analyzer</span>. <span>International Journal for Vitamin and Nutrition Research</span> <span>1990</span>;<span>60</span>:<span>126-35</span>. [CAB DIRECT RECORD NUMBER: <span>19901451895</span>]</span>
      </li>
      <li id="421727649960053670">
        <span publication-type="book"><span person-group-type="author"><span><span>Henry</span> <span>RJ</span></span></span>. <span>Clinical chemistry: principles and techniques</span>. <span>New York</span>: <span>Harper and Row</span>, <span>1974</span>. </span>
      </li>
      <li id="421741042645883725">
        <span publication-type="book-section"><span person-group-type="author"><span><span>Lohman</span> <span>TG</span></span>, <span><span>Roche</span> <span>AF</span></span>, <span><span>Martorell</span> <span>R</span></span></span>. <span>Reliability and accuracy of measurements</span>. In: <span>Anthropometric standardization reference manual</span>. <span>Champaign</span>: <span>Human kinetics books</span>, <span>1988</span>:<span>83-6</span>.</span>
      </li>
      <li id="421741100637117265">
        <span publication-type="book"><span person-group-type="author"><span><span>Hamill</span> <span>PV</span></span>, <span><span>Drizd</span> <span>TA</span></span>, <span><span>Johnson</span> <span>CL</span></span>, <span><span>Reed</span> <span>RB</span></span>, <span><span>Roche</span> <span>AF</span></span></span>. <span>NCHS growth curve for children: birth-18y</span>. <span>Washington DC</span>: <span>Department of Health Education and Welfare</span>, <span>1977</span>. </span>
      </li>
      <li id="421741242276928344">
        <span publication-type="journal"><span person-group-type="author"><span><span>Frisancho</span> <span>AR</span></span></span>. <span>New norms of upper limb fat and muscle areas for assessment of nutritional status</span>. <span>American Journal of Clinical Nutrition</span> <span>1981</span>;<span>34</span>(<span>11</span>):<span>2540-5</span>. [DOI: <a href="https://doi.org/10.1093/ajcn/34.11.2540">10.1093/ajcn/34.11.2540</a>]</span>
      </li>
      <li id="421741367020510042">
        <span publication-type="journal"><span person-group-type="author"><span><span>Von Schenck</span> <span>H</span></span>, <span><span>Falkensson</span> <span>M</span></span>, <span><span>Lundberg</span> <span>B</span></span></span>. <span>Evaluation of" HemoCue", a new device for determining hemoglobin</span>. <span>Clinical chemistry</span> <span>1986</span>;<span>32</span>(<span>3</span>):<span>526-9</span>. [DOI: <a href="https://doi.org/10.1093/clinchem/32.3.526">10.1093/clinchem/32.3.526</a>]</span>
      </li>
      <li id="421741387201665884">
        <span publication-type="journal"><span person-group-type="author"><span><span>Addison</span> <span>GM</span></span>, <span><span>Beamish</span> <span>MR</span></span>, <span><span>Hales</span> <span>CN</span></span>, <span><span>Hodgkins</span> <span>M</span></span>, <span><span>Jacobs</span> <span>A</span></span>, <span><span>Llewellin</span> <span>P</span></span></span>. <span>An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload</span>. <span>Journal of Clinical Pathology</span> <span>1972</span>;<span>25</span>(<span>4</span>):<span>326-9</span>. [DOI: <a href="https://doi.org/10.1136/jcp.25.4.326">10.1136/jcp.25.4.326</a>]</span>
      </li>
      <li id="421741420403776350">
        <span publication-type="journal"><span person-group-type="author"><span><span>Thurnham</span> <span>DI</span></span>, <span><span>Smith</span> <span>E</span></span>, <span><span>Flora</span> <span>PS</span></span></span>. <span>Concurrent liquid-chromatographic assay of retinol, a-tocopherol, &szlig;-carotene, a-carotene, lycopene, and &szlig;-cryptoxanthin in plasma, with tocopherol acetate as internal standard</span>. <span>Clinical Chemistry</span> <span>1988</span>;<span>34</span>:<span>377-81</span>.</span>
      </li>
      <li id="421723125860288599">
        <span publication-type="book"><span person-group-type="author"><span><span>Bayley</span> <span>N</span></span></span>. <span>Bayley Scales of Infant Development Manual</span>. <span>New York</span>: <span>Psychological Corporation</span>, <span>1969</span>. </span>
      </li>
      <li id="421742670737072849">
        <span publication-type="book"><span person-group-type="author"><span><span>Caldwell</span> <span>BM</span></span></span>. <span>Instruction manual: home inventory for infants</span>. Revised edition. <span>Little Rock</span>: <span>University of Arkansas. Center for Early Child Development</span>, <span>1975</span>. </span>
      </li>
      <li id="421741576699011675">
        <span publication-type="journal"><span person-group-type="author"><span><span>Schretlen</span> <span>D</span></span>, <span><span>Bobholz</span> <span>JH</span></span>, <span><span>Brandt</span> <span>J</span></span></span>. <span>Development and psychometric properties of the Brief Test of Attention</span>. <span>The Clinical Neuropsychologist</span> <span>1996</span>;<span>10</span>(<span>1</span>):<span>80-9</span>. [DOI: <a href="https://doi.org/10.1080/13854049608406666">10.1080/13854049608406666</a>]</span>
      </li>
      <li id="421741595884806753">
        <span publication-type="book"><span person-group-type="author"><span><span>Smith</span> <span>A</span></span></span>. <span>Symbol Digit Modalities Test</span>. <span>Los Angeles</span>: <span>Western Psychological Services</span>, <span>1973</span>. </span>
      </li>
      <li id="421741639007494789">
        <span publication-type="book"><span person-group-type="author"><span><span>Trenerry</span> <span>MR</span></span>, <span><span>Crosson</span> <span>B</span></span>, <span><span>Deboe</span> <span>J</span></span>, <span><span>Leber</span> <span>WR</span></span></span>. <span>Visual Search and Attention Test: Professional Manual</span>. <span>Odessa</span>: <span>Psychological Assessment Resources</span>, <span>1990</span>. </span>
      </li>
      <li id="421741660540002950">
        <span publication-type="journal"><span person-group-type="author"><span><span>Brandt</span> <span>J</span></span></span>. <span>The Hopkins Verbal Learning Test: Development of a new memory test with six equivalent forms</span>. <span>The Clinical Neuropsychologist</span> <span>1991</span>;<span>5</span>(<span>2</span>):<span>125-42</span>. [DOI: <a href="https://doi.org/10.1080/13854049108403297">10.1080/13854049108403297</a>]</span>
      </li>
    </ol>
  </body>
</html>
